ArticleWorld journal of clinical cases2024
Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen 125, carbohydrate antigen 199 analysis.
Dong-Bing Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.